Latest Cover
Welcome to Progress in Neurology and Psychiatry’s dedicated website. Progress is for health professionals in secondary and primary care looking after patients with neurological and psychiatric diseases. If you are a health professional working in the field of neurology or psychiatry you can register with us for free access to our content.Sign up for e-alerts and print copies

Latest News

Email based interventions could improve mental health

Health interventions conducted via email may improve mental health according to a study published in BMC Psychology.Conducted in Finland, the study found...Read more

Amphetamine for ADHD available in US

Dyanavel XR (amphetamine), the first and only extended-release liquid amphetamine for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in...Read more

Daclizumab improves cognition in MS patients

Daclizumab (Zinbryta) improves cognition in patients with Multiple Sclerosis, according to research revealed at the 68th Annual Meeting of the American Academy...Read more

Action urged to tackle smoking in people with mental health conditions

Action on Smoking and Health (ASH) says ‘urgent action’ is needed to tackle the high smoking rate among people with mental health conditions, according a...Read more

Maintenance treatment for schizophrenia recommended

The Committee for Medicinal Products for Human Use has adopted a ‘positive opinion’ recommending paliperidone palmitate for the treatment of...Read more

Featured Articles

Cognitive screening instruments for the diagnosis of mild cognitive impairment
Mild cognitive impairment (MCI) may represent an early, and potentially treatable, phase of dementing disorders. Its correct clinical identification is therefore of paramount importance. Here, Dr Larner analyses data from a selection of short cognitive screening instruments…
Click here to view

Neuroimaging in dementia: an update for the general clinician
Structural neuroimaging is a fundamental part of a routine dementia assessment to rule out treatable causes of cognitive impairment, and to support early, accurate dementia subtype diagnosis.
Click here to view

Pharmacological management of epilepsy
There have been significant advances in the management of epilepsy since the appearance of bromide in 1857. In the last decade, many new drugs have been developed and general understanding of the condition has improved.
Click here to view

Web design and marketing agency Leamington Spa